Anupam Rasayan has signed Letter of Intent (LoI) worth revenue of $265 Million (Rs 2,186 crore) for next 5 years with one of the leading Japanese Speciality Chemical company to supply new age patented life science active ingredient. The product will be in validation phase for the next eighteen months and upon the successful validation, the supply will commence from CY2025. This product will be manufactured in our existing multipurpose manufacturing facilities.
Anupam Rasayan India (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.
| Company Name | CMP |
|---|---|
| SRF | 2740.40 |
| BASF India | 3528.10 |
| Pidilite Inds. | 1580.60 |
| Tata Chemicals | 714.05 |
| Deepak Nitrite | 1667.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: